vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $124.7M, roughly 1.7× SMITH & WESSON BRANDS, INC.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs 1.5%, a 1.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -4.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
IRTC vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $124.7M |
| Net Profit | $5.6M | $1.9M |
| Gross Margin | 70.9% | 24.3% |
| Operating Margin | 1.1% | 3.3% |
| Net Margin | 2.7% | 1.5% |
| Revenue YoY | 27.1% | -3.9% |
| Net Profit YoY | 518.5% | -53.6% |
| EPS (diluted) | $0.18 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $124.7M | ||
| Q3 25 | $192.9M | $85.1M | ||
| Q2 25 | $186.7M | $140.8M | ||
| Q1 25 | $158.7M | $115.9M | ||
| Q4 24 | $164.3M | $129.7M | ||
| Q3 24 | $147.5M | $88.3M | ||
| Q2 24 | $148.0M | $159.1M | ||
| Q1 24 | $131.9M | $137.5M |
| Q4 25 | $5.6M | $1.9M | ||
| Q3 25 | $-5.2M | $-3.4M | ||
| Q2 25 | $-14.2M | $8.6M | ||
| Q1 25 | $-30.7M | $2.1M | ||
| Q4 24 | $-1.3M | $4.5M | ||
| Q3 24 | $-46.2M | $-1.9M | ||
| Q2 24 | $-20.1M | $27.9M | ||
| Q1 24 | $-45.7M | $7.9M |
| Q4 25 | 70.9% | 24.3% | ||
| Q3 25 | 71.1% | 25.9% | ||
| Q2 25 | 71.2% | 28.8% | ||
| Q1 25 | 68.8% | 24.1% | ||
| Q4 24 | 70.0% | 26.6% | ||
| Q3 24 | 68.8% | 27.4% | ||
| Q2 24 | 69.9% | 35.5% | ||
| Q1 24 | 66.3% | 28.7% |
| Q4 25 | 1.1% | 3.3% | ||
| Q3 25 | -4.4% | -3.5% | ||
| Q2 25 | -10.0% | 9.3% | ||
| Q1 25 | -20.5% | 4.1% | ||
| Q4 24 | -2.5% | 5.8% | ||
| Q3 24 | -34.1% | -1.7% | ||
| Q2 24 | -15.5% | 17.4% | ||
| Q1 24 | -28.9% | 8.2% |
| Q4 25 | 2.7% | 1.5% | ||
| Q3 25 | -2.7% | -4.0% | ||
| Q2 25 | -7.6% | 6.1% | ||
| Q1 25 | -19.3% | 1.8% | ||
| Q4 24 | -0.8% | 3.5% | ||
| Q3 24 | -31.3% | -2.1% | ||
| Q2 24 | -13.6% | 17.5% | ||
| Q1 24 | -34.6% | 5.7% |
| Q4 25 | $0.18 | $0.04 | ||
| Q3 25 | $-0.16 | $-0.08 | ||
| Q2 25 | $-0.44 | $0.19 | ||
| Q1 25 | $-0.97 | $0.05 | ||
| Q4 24 | $-0.03 | $0.10 | ||
| Q3 24 | $-1.48 | $-0.04 | ||
| Q2 24 | $-0.65 | $0.60 | ||
| Q1 24 | $-1.47 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $363.2M |
| Total Assets | $1.0B | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $22.4M | ||
| Q3 25 | $565.2M | $18.0M | ||
| Q2 25 | $545.5M | $25.2M | ||
| Q1 25 | $520.6M | $26.7M | ||
| Q4 24 | $535.6M | $39.1M | ||
| Q3 24 | $522.0M | $35.5M | ||
| Q2 24 | $561.5M | $60.8M | ||
| Q1 24 | $569.1M | $47.4M |
| Q4 25 | $152.7M | $363.2M | ||
| Q3 25 | $121.9M | $364.4M | ||
| Q2 25 | $103.7M | $372.5M | ||
| Q1 25 | $86.7M | $366.9M | ||
| Q4 24 | $90.9M | $371.5M | ||
| Q3 24 | $71.8M | $380.0M | ||
| Q2 24 | $99.2M | $399.9M | ||
| Q1 24 | $90.3M | $376.4M |
| Q4 25 | $1.0B | $548.6M | ||
| Q3 25 | $995.2M | $554.6M | ||
| Q2 25 | $964.0M | $559.6M | ||
| Q1 25 | $926.1M | $578.9M | ||
| Q4 24 | $931.4M | $587.4M | ||
| Q3 24 | $909.7M | $571.3M | ||
| Q2 24 | $919.2M | $577.4M | ||
| Q1 24 | $909.8M | $570.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $27.3M |
| Free Cash FlowOCF − Capex | $14.5M | $16.3M |
| FCF MarginFCF / Revenue | 6.9% | 13.1% |
| Capex IntensityCapex / Revenue | 5.6% | 8.8% |
| Cash ConversionOCF / Net Profit | 4.70× | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $27.3M | ||
| Q3 25 | $34.9M | $-8.1M | ||
| Q2 25 | $27.7M | $40.8M | ||
| Q1 25 | $-7.9M | $-9.8M | ||
| Q4 24 | $19.2M | $-7.4M | ||
| Q3 24 | $24.3M | $-30.8M | ||
| Q2 24 | $11.8M | $43.7M | ||
| Q1 24 | $-52.0M | $25.2M |
| Q4 25 | $14.5M | $16.3M | ||
| Q3 25 | $20.1M | $-12.4M | ||
| Q2 25 | $17.3M | $33.5M | ||
| Q1 25 | $-17.3M | $-16.1M | ||
| Q4 24 | $12.4M | $-10.7M | ||
| Q3 24 | $15.5M | $-35.5M | ||
| Q2 24 | $3.4M | $38.2M | ||
| Q1 24 | $-61.8M | $7.0M |
| Q4 25 | 6.9% | 13.1% | ||
| Q3 25 | 10.4% | -14.6% | ||
| Q2 25 | 9.3% | 23.8% | ||
| Q1 25 | -10.9% | -13.9% | ||
| Q4 24 | 7.5% | -8.3% | ||
| Q3 24 | 10.5% | -40.2% | ||
| Q2 24 | 2.3% | 24.0% | ||
| Q1 24 | -46.8% | 5.1% |
| Q4 25 | 5.6% | 8.8% | ||
| Q3 25 | 7.7% | 5.0% | ||
| Q2 25 | 5.6% | 5.2% | ||
| Q1 25 | 5.9% | 5.4% | ||
| Q4 24 | 4.2% | 2.5% | ||
| Q3 24 | 6.0% | 5.3% | ||
| Q2 24 | 5.7% | 3.5% | ||
| Q1 24 | 7.4% | 13.2% |
| Q4 25 | 4.70× | 14.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.73× | ||
| Q1 25 | — | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
SWBI
Segment breakdown not available.
